adlitterio66339

About adlitterio66339

This author has not yet filled in any details.
So far adlitterio66339 has created 727 blog entries.

11 12, 2024

Diatech Pharmacogenetics will atten the 26th “Bamberger Morphologietage” Congress from January 24 to 26
Diatech Pharmacogenetics will atten the 26th “Bamberger Morphologietage” Congress from January 24 to 26

Events, News

Diatech Pharmacogenetics will atten the 26th “Bamberger Morphologietage” Congress from January 24 to 26

adlitterio663392024-12-11T12:47:07+01:00

2 12, 2024

Federico Nichetti et al., Molecular characterization and clinical relevance of MGMT-silenced pancreatic cancer

adlitterio663392024-12-02T14:23:03+01:00

29 11, 2024

Ilaria Proietti et al., BRAF-mutant melanoma management: a single center retrospective analysis of patients treated with sequential therapy

adlitterio663392024-11-29T14:16:14+01:00

19 11, 2024

Diatech Pharmacogenetics willl attend the XIII Molecular Cytopathology of Naples – December 9-10, 2024
Diatech Pharmacogenetics willl attend the XIII Molecular Cytopathology of Naples – December 9-10, 2024

Events, News

Diatech Pharmacogenetics willl attend the XIII Molecular Cytopathology of Naples – December 9-10, 2024

adlitterio663392024-11-19T14:14:15+01:00

19 11, 2024

Rosanna Squitti et al., Copper dysmetabolism is connected to epithelial-mesenchymal transition: A pilot study in colorectal cancer patients

adlitterio663392024-11-19T12:58:51+01:00

19 11, 2024

Diatech Pharmacogenetics will attend the Pathologists in Venice Congress – December 12 -13, 2024
Diatech Pharmacogenetics will attend the Pathologists in Venice Congress – December 12 -13, 2024

Events, News

Diatech Pharmacogenetics will attend the Pathologists in Venice Congress – December 12 -13, 2024

adlitterio663392024-11-19T14:19:03+01:00

15 11, 2024

Krishnamurthy Hari et al., Classification of colorectal cancer patients based on serum micronutrients: An exploratory investigation

adlitterio663392025-01-02T13:02:14+01:00

13 11, 2024

Shooting Cancer Highlights – Periodic focus on regulatory status of new targeted therapies in oncology

adlitterio663392024-11-15T11:49:38+01:00

30 10, 2024

Laura Simone et al., Tailored treatment and clinical management for DPYD compound heterozygous: a multidisciplinary teamwork

adlitterio663392024-10-30T11:30:50+01:00

28 10, 2024

Pasquale Pisapia et al., The relevance of the reference range for EGFR testing in non-small cell lung cancer patients

adlitterio663392024-10-28T11:27:03+01:00

Previous 234 Next